Provided is a fetal heart rate variability monitoring device capable of easily determining a fetal condition. A fetal heart rate variability monitoring device includes a processing unit and a display unit that acquire a fetal heart rate and display a fetal heart rate diagram showing the fetal heart rate over time, an LTV and STV conversion processing unit that calculates STV and LTV from the fetal heart rate, and an event input unit that can designate a predetermined period on the fetal heart rate diagram. The processing unit and the display unit have a function of issuing notification of the STV and LTV in the predetermined period calculated by the LTV and STV conversion processing unit when the predetermined period is designated by the event input unit.

A computer-implemented method includes providing, by at least one computer processor, a plurality of signal channels, wherein the plurality of signal channels includes a plurality of electrical uterine monitoring signal channels and a plurality of acoustic uterine monitoring signal channels; determining, by the at least one computer processor, a plurality of channel weights, wherein each of the channel weights corresponds to a particular one of the signal channels; and generating, by the at least one computer processor, a combined uterine monitoring signal channel by calculating a weighted average of the signal channels based on the channel weight for each of the signal channels.

A method of fetal ultrasound monitoring includes detecting contact of a first ultrasound transducer to a mother's abdomen based on input from a contact sensor in the first ultrasound transducer. A first transducer ID is received from the first ultrasound transducer, and then the first transducer ID is correlated with a first transducer label. A first heart rate is measured based on output of an ultrasound device in the first ultrasound transducer, and a heart rate indicator is displayed accordingly. A position of the first ultrasound transducer is identified in a two-dimensional plane, and the first transducer label is displayed on an abdomen image based on the first position.

A computer-implemented method includes providing, by at least one computer processor, a plurality of signal channels, wherein the plurality of signal channels includes a plurality of electrical uterine monitoring signal channels and a plurality of acoustic uterine monitoring signal channels; determining, by the at least one computer processor, a plurality of channel weights, wherein each of the channel weights corresponds to a particular one of the signal channels; and generating, by the at least one computer processor, a combined uterine monitoring signal channel by calculating a weighted average of the signal channels based on the channel weight for each of the signal channels.

A system for sensing physiological traits of a maternal patient and a fetal patient carried by the maternal patient during a pregnancy using one or more sensors. The system may use the physiological traits sensed to define a maternal attribute for the maternal patient and a fetal attribute for the fetal patient, such as a heart rate, blood pressure, respiration rate, temperature, oxygen saturation level, or other attributes. The system is configured to compare the maternal attribute to a maternal limit describing a threshold for the maternal patient and/or compare the fetal attribute to a fetal limit describing a threshold for the fetal patient. The system is configured to issue a communication to the maternal patient and/or a clinician based on the comparisons. In examples, the system regularly communicates the maternal attribute and/or the fetal attribute to an output device of the maternal patient and/or a clinician.

Provided is a biological information detection device capable of restraining noise from being mixed with a signal relating to biological information. A biological information detection device includes an electrode pad that is able to detect a signal (bioelectric signal) relating to biological information of a subject (for example, a fetus in a mother's body), a connector that is connectable to the electrode pad, and a cable that is connected to the connector and is able to transmit the signal. The electrode pad and the connector are provided with fixing members and that are attachable to and detachable from each other, respectively.

A system for monitoring the fetal size of an expectant mother comprises an acoustic sensor for positioning over the belly of the expectant mother, the acoustic sensor configured to receive an acoustic signal generated by the fetal heartbeat and to generate a sensor output signal. A fetal size is determined from a sensor output signal strength. This system is based on the realization that certain acoustic signals generated by the fetal heart beat are strongly correlated with the fetus size.

A multi-sensor patch for simultaneous abdominal monitoring of maternal and fetal physiological data includes a multi-layer flexible substrate. The multi-layer flexible substrate includes a center region and a plurality of electrode regions. An electrode of the plurality of electrodes is located in each of the electrode regions. At least one auxiliary sensor which may be an optical sensor. A module unit is connected to the conductive layer at the center region. The module unit is configured to receive biopotential physiological data from the plurality of electrodes and photosignal data from the optical sensor. The module unit calculates at least fetal heart rate (fHR), maternal heart rate (mHR), and uterine activity (UA) from the biopotential physiological data and fHR, mHR, and SpO2 from the photosignal data.

During childbirth process, trauma to an infant can readily arise, ultimately resulting in fetal hypoxia, academia, and brain damage. Such unfavorable conditions can be prevented by measuring the fetus' blood-oxygen level and heart rate. Without a fetal pulse oximeters, blood oxygen level cannot be monitored non-invasively reliably, which reduces the chance for birth complications to be recognized in time. A noninvasive system to implement such goals and maximize the potential welfare of the fetus may include devices to measure oxygen saturation of hemoglobin (SpO2) that have been available for at least 50 years. Such a device may be an oxy probe that uses a trans-reflective method of SpO2 measurement where oxygen saturation data can be transmitted through wire, fiber optics, and or using a radio frequency link, fetal monitor data can be analyzed, compared to existing data base, and or transmitted via radio waves or internet.

A method and device for measuring intra-abdominal pressure in a pregnant woman to assess likelihood or occurrence of pre-eclampsia. The method includes providing a catheter having first and second lumens and a balloon, inserting the catheter into a bladder of the patient, injecting gas into the first lumen of the catheter to expand the balloon, obtaining a first pressure reading of the bladder based on deformation of the balloon to thereby monitor pressure within an abdomen of the mother to assess if pre-eclampsia is occurring or likely to occur and transmitting the first pressure reading to an external monitor connected to the catheter. The pressure reading is indicative of the presence and/or risk of pre-eclampsia to determine when intervention should occur to prevent morbidity and mortality of the woman and baby.